While patients with IRAb classically have TBIRS presenting with severe insulin resistance and hyperglycaemia requiring high doses of insulin therapy (4), more than 10% of patients with IRAb present with autoimmune hypoglycaemia alone. This evidence concerns the gene INS and Hyperglycemia.